retatrutide clinical trial texas Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 ESC 2024: Retatrutide improves lipid

At that point, they can recommend a maintenance dose that can help you sustain the weight youve lost

It is not a substitute for professional diagnosis or treatment

NICE guideline CG189 ( Obesity: identification, assessment and management ) and NICE public health guidance PH53 ( Weight management: lifestyle services for overweight or obese adults ) outline a stepped-care approach, which may include: Tier 2 community-based lifestyle and behavioural interventions Tier 3 specialist multidisciplinary weight management services Pharmacotherapy , where clinically appropriate for example, orlistat (subject to BNF/MHRA prescribing criteria and available via GP or specialist services) or semaglutide 2.4 mg (Wegovy), which is approved by NICE technology appraisal TA875 for use within specialist NHS weight management services for adults meeting defined BMI and comorbidity thresholds Bariatric surgery in selected cases, as outlined in NICE CG189 Pharmacotherapy for weight management should only be initiated and monitored in accordance with NICE, BNF, and MHRA guidance, and within appropriate clinical services

What is AOD9604 used for in research

Pack, S.P